| Literature DB >> 31888991 |
Mengran Chen1,2,3, Han Pan1,2, Lingfei Sun2, Peng Shi4, Yikan Zhang2, Le Li2, Yuxing Huang4, Jianhui Chen2, Peng Jiang2, Xianyang Fang2, Congying Wu4, Zhucheng Chen5,2.
Abstract
Epithelial cell transforming 2 (Ect2) protein activates Rho GTPases and controls cytokinesis and many other cellular processes. Dysregulation of Ect2 is associated with various cancers. Here, we report the crystal structure of human Ect2 and complementary mechanistic analyses. The data show the C-terminal PH domain of Ect2 folds back and blocks the canonical RhoA-binding site at the catalytic center of the DH domain, providing a mechanism of Ect2 autoinhibition. Ect2 is activated by binding of GTP-bound RhoA to the PH domain, which suggests an allosteric mechanism of Ect2 activation and a positive-feedback loop reinforcing RhoA signaling. This bimodal RhoA binding of Ect2 is unusual and was confirmed with Förster resonance energy transfer (FRET) and hydrogen-deuterium exchange mass spectrometry (HDX-MS) analyses. Several recurrent cancer-associated mutations map to the catalytic and regulatory interfaces, and dysregulate Ect2 in vitro and in vivo. Together, our findings provide mechanistic insights into Ect2 regulation in normal cells and under disease conditions.Entities:
Keywords: Ect2; RhoA; biophysics; cancer; cytokinesis
Mesh:
Substances:
Year: 2019 PMID: 31888991 PMCID: PMC6969500 DOI: 10.1073/pnas.1913054117
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205